Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Razaq, Wajeeha
One or more keywords matched the following properties of Razaq, Wajeeha
PropertyValue
Person ID 4820
phone 405/271-4022
One or more keywords matched the following items that are connected to Razaq, Wajeeha
Item TypeName
Concept Imatinib Mesylate
Concept Rituximab
Concept Antibodies, Monoclonal
Concept Alanine Transaminase
Concept Adenocarcinoma
Concept Carcinoma, Squamous Cell
Concept Benzamides
Concept C-Reactive Protein
Concept Etoposide
Concept Carcinoma, Adenoid Cystic
Concept Endothelium, Vascular
Concept Eosinophils
Concept Humans
Concept Germ Cells
Concept Insulin-Like Growth Factor I
Concept Leukocytes, Mononuclear
Concept Interferons
Concept Mice, Inbred BALB C
Concept Mice, Inbred ICR
Concept Pilot Projects
Concept Salivary Gland Neoplasms
Concept Retrospective Studies
Concept Quality of Life
Concept Lymphoma, B-Cell, Marginal Zone
Concept Risk Assessment
Concept Hyaluronan Receptors
Concept Lymphoma, B-Cell
Concept Receptor, ErbB-2
Concept Carcinoma, Mucoepidermoid
Concept Mice, Knockout
Concept Carcinoma, Ductal
Concept Antibodies, Monoclonal, Murine-Derived
Concept Tumor Necrosis Factor-alpha
Concept Interleukin-6
Concept Complement C3a
Concept Complement C5a
Concept Survival Rate
Concept Cytokines
Concept Cell Proliferation
Concept Ki-67 Antigen
Concept Aptamers, Nucleotide
Concept Aspartate Aminotransferases
Concept Follow-Up Studies
Concept Immunohistochemistry
Concept Oxyhemoglobins
Academic Article Accelerated vascular aging and persistent cognitive impairment in older female breast cancer survivors.
Academic Article The effect of soluble E-selectin on tumor progression and metastasis.
Academic Article Hormonal receptor evaluation in salivary duct adenocarcinoma.
Academic Article Evaluating the Response of Palbociclib on Progression-Free Survival in Hormone Receptor-Positive Metastatic Breast Cancer.
Academic Article Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (EA2108).
Academic Article Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical Trial.
Search Criteria
  • Receptor
  • ErbB
  • 4